{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:34:45Z","timestamp":1773905685651,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ajp.2022.103092","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T19:30:21Z","timestamp":1649273421000},"page":"103092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Effects of the selective serotonin reuptake inhibitor fluoxetine on glucose metabolism: A systematic review"],"prefix":"10.1016","volume":"73","author":[{"given":"Zizhen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2022.103092_bib1","article-title":"Antidepressants versus placebo for people with bulimia nervosa","volume":"4","author":"Bacaltchuk","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.ajp.2022.103092_bib2","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2337\/dc13-0560","article-title":"Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review","volume":"36","author":"Barnard","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ajp.2022.103092_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4306\/pi.2013.10.2.148","article-title":"Relationship between SSRIs and metabolic syndrome abnormalities in patients with generalized anxiety disorder: a prospective study","volume":"10","author":"Beyazy\u00fcz","year":"2013","journal-title":"Psychiatry Investig."},{"issue":"5","key":"10.1016\/j.ajp.2022.103092_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.12998\/wjcc.v1.i5.169","article-title":"Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes","volume":"1","author":"Biagetti","year":"2013","journal-title":"World J. Clin. Cases"},{"issue":"12","key":"10.1016\/j.ajp.2022.103092_bib5","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0026-0495(95)90077-2","article-title":"Long-term effects of fluoxetine on glycemic control in obese patients with noninsulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity","volume":"44","author":"Breum","year":"1995","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.ajp.2022.103092_bib6","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.2337\/db08-1000","article-title":"Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes","volume":"57","author":"Briscoe","year":"2008","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.ajp.2022.103092_bib7","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/db08-0236","article-title":"Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals","volume":"57","author":"Briscoe","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ajp.2022.103092_bib8","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2147\/NDT.S167608","article-title":"Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial","volume":"14","author":"Che","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"10128","key":"10.1016\/j.ajp.2022.103092_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ajp.2022.103092_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.psym.2013.02.015","article-title":"Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort","volume":"54","author":"Coleman","year":"2013","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.ajp.2022.103092_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/j.1550-8528.1996.tb00247.x","article-title":"Usefulness of fluoxetine in obese noninsulin-dependent diabetics: a multicenter study","volume":"4","author":"Daubresse","year":"1996","journal-title":"Obes. Res."},{"issue":"5","key":"10.1016\/j.ajp.2022.103092_bib12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1464-5491.1995.tb00505.x","article-title":"A study of fluoxetine in obese elderly patients with type 2 diabetes","volume":"12","author":"Connolly","year":"1995","journal-title":"Diabet. Med."},{"issue":"3","key":"10.1016\/j.ajp.2022.103092_bib13","first-page":"262","article-title":"Hypoglycemia associated with the use of fluoxetine","volume":"164","author":"Deeg","year":"1996","journal-title":"West J. Med."},{"issue":"5","key":"10.1016\/j.ajp.2022.103092_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.genhosppsych.2010.06.004","article-title":"Association between major depression, depressive symptoms and personal income in US adults with diabetes","volume":"32","author":"Dismuke","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"12","key":"10.1016\/j.ajp.2022.103092_bib15","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.2337\/dc08-0175","article-title":"Depression: an important comorbidity with metabolic syndrome in a general population","volume":"31","author":"Dunbar","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajp.2022.103092_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.genhosppsych.2016.01.002","article-title":"Psychiatric referral and glycemic control of Egyptian type 2 diabetes mellitus patients with depression","volume":"40","author":"Fawzi","year":"2016","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2022.103092_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.jcp.0000132441.27854.0d","article-title":"Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder","volume":"24","author":"Ghaeli","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.ajp.2022.103092_bib18","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/diacare.27.7.1761","article-title":"Tests of glycemia in diabetes","volume":"27","author":"Goldstein","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajp.2022.103092_bib19","first-page":"481","article-title":"Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success","volume":"4","author":"Goldstein","year":"1995","journal-title":"Obes. Res."},{"issue":"9","key":"10.1016\/j.ajp.2022.103092_bib20","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.2337\/dc07-0158","article-title":"Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity","volume":"30","author":"Gonzalez","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ajp.2022.103092_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/10401230109147127","article-title":"Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy","volume":"13","author":"Goodnick","year":"2001","journal-title":"Ann. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2022.103092_bib22","first-page":"193","article-title":"Fluoxetine treatment of the obese diabetic","volume":"16","author":"Gray","year":"1992","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"6","key":"10.1016\/j.ajp.2022.103092_bib23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1590\/S0004-27302006000600007","article-title":"Tolerability and effectiveness of fluoxetine, metformin and sibutramine in reducing anthropometric and metabolic parameters in obese patients","volume":"50","author":"Guimar\u00e3es","year":"2006","journal-title":"Arq. Bras. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ajp.2022.103092_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arcmed.2004.12.018","article-title":"Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients","volume":"36","author":"Gulseren","year":"2005","journal-title":"Arch. Med. Res."},{"issue":"9","key":"10.1016\/j.ajp.2022.103092_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0006-3223(98)00195-4","article-title":"Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa","volume":"44","author":"Kaye","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2022.103092_bib26","first-page":"42","article-title":"Treatment of depression in type 2 diabetes with fluoxetine or citalopram?","volume":"16","author":"Khazaie","year":"2011","journal-title":"Neurosciences"},{"issue":"8804","key":"10.1016\/j.ajp.2022.103092_bib27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/0140-6736(92)91624-H","article-title":"Fluoxetine side-effects mimicking hypoglycemia","volume":"339","author":"Lear","year":"1992","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ajp.2022.103092_bib28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/diacare.23.5.618","article-title":"Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial","volume":"23","author":"Lustman","year":"2000","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ajp.2022.103092_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.ijo.0800372","article-title":"Fluoxetine improves insulin sensitivity in obese patients with noninsulin-dependent diabetes mellitus independent of weight loss","volume":"21","author":"Maheux","year":"1997","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"7","key":"10.1016\/j.ajp.2022.103092_bib30","article-title":"Fluoxetine versus other types of pharmacotherapy for depression","volume":"17","author":"Magni","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.ajp.2022.103092_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.jcp.0000095341.32154.8f","article-title":"African women with depression: the effect of imipramine and fluoxetine on body mass index and leptin secretion","volume":"23","author":"Moosa","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2022.103092_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1464-5491.1994.tb00238.x","article-title":"Fluoxetine in the treatment of obese type 2 diabetic patients","volume":"11","author":"O\u2019Kane","year":"1994","journal-title":"Diabet. Med."},{"issue":"1","key":"10.1016\/j.ajp.2022.103092_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/meta.2002.26712","article-title":"Does fluoxetine administration influence insulin resistance in 90% pancreatectomized rats?","volume":"51","author":"Park","year":"2002","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.ajp.2022.103092_bib34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cpcardiol.2017.04.004","article-title":"Obesity and cardiovascular diseases","volume":"42","author":"Parto","year":"2017","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ajp.2022.103092_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jad.2020.01.154","article-title":"Obesity increases the risk of depression in children and adolescents: Results from a systematic review and meta-analysis","volume":"267","author":"Rao","year":"2020","journal-title":"J. Affect Disord."},{"issue":"3","key":"10.1016\/j.ajp.2022.103092_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/neu.2016.54","article-title":"Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review","volume":"29","author":"Roopan","year":"2017","journal-title":"Acta Neuropsychiatr."},{"issue":"Suppl","key":"10.1016\/j.ajp.2022.103092_bib37","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","article-title":"Epidemiology of depression and diabetes: a systematic review","volume":"142","author":"Roy","year":"2012","journal-title":"J. Affect Disord."},{"issue":"1","key":"10.1016\/j.ajp.2022.103092_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.31887\/DCNS.2018.20.1\/nsartorius","article-title":"Depression and diabetes","volume":"20","author":"Sartorius","year":"2018","journal-title":"Dialog-. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.ajp.2022.103092_bib39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1067\/mpd.2000.103851","article-title":"Loss of hypoglycemia awareness in an adolescent with type 1 diabetes mellitus during treatment with fluoxetine hydrochloride","volume":"136","author":"Sawka","year":"2000","journal-title":"J. Pediatr."},{"issue":"10","key":"10.1016\/j.ajp.2022.103092_bib40","article-title":"Fluoxetine for adults who are overweight or obese","volume":"10","author":"Serralde-Z\u00fa\u00f1iga","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ajp.2022.103092_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2008-2231-21-4","article-title":"Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression","volume":"21","author":"Shahsavand Ananloo","year":"2013","journal-title":"Daru"},{"key":"10.1016\/j.ajp.2022.103092_bib42","article-title":"Fluoxetine","volume":"2021","author":"Sohel","year":"2021"},{"issue":"8","key":"10.1016\/j.ajp.2022.103092_bib43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ijo.2013.225","article-title":"A comparative study of five centrally acting drugs on the pharmacological treatment of obesity","volume":"38","author":"Suplicy","year":"2014","journal-title":"Int. J. Obes."},{"issue":"10","key":"10.1016\/j.ajp.2022.103092_bib44","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14728222.2019.1675639","article-title":"Fluoxetine induces glucose uptake and modifies glucose transporter palmitoylation in human peripheral blood mononuclear cells","volume":"23","author":"Stapel","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"issue":"7","key":"10.1016\/j.ajp.2022.103092_bib45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/PSY.0000000000000707","article-title":"The association between selective serotonin reuptake inhibitors and glycemia: a systematic review and meta-analysis of randomized controlled trials","volume":"81","author":"Tharmaraja","year":"2019","journal-title":"Psychosom. Med."},{"issue":"2","key":"10.1016\/j.ajp.2022.103092_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/j.1550-8528.1994.tb00641.x","article-title":"No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, andor blood pressure in healthy men with abdominal obesity","volume":"2","author":"Visser","year":"1994","journal-title":"Obes. Res."},{"issue":"3","key":"10.1016\/j.ajp.2022.103092_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MOL.0b013e3283462273","article-title":"Role of peripheral serotonin in glucose and lipid metabolism","volume":"22","author":"Watanabe","year":"2011","journal-title":"Curr. Opin. Lipido"},{"issue":"3","key":"10.1016\/j.ajp.2022.103092_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-2999(99)00593-2","article-title":"SelectiveThe selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms","volume":"382","author":"Yamada","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.ajp.2022.103092_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021551","article-title":"Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials","volume":"6","author":"Ye","year":"2011","journal-title":"PLoS One"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201822000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201822000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:44:58Z","timestamp":1761756298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201822000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":49,"alternative-id":["S1876201822000909"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2022.103092","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the selective serotonin reuptake inhibitor fluoxetine on glucose metabolism: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2022.103092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103092"}}